Abstract
Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Current Medicinal Chemistry
Title: Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection
Volume: 11 Issue: 4
Author(s): John D. Noti
Affiliation:
Keywords: leukocyte integrins, transplantation, ischemic reperfusion injury, graft-versus-host
Abstract: Many immune responses are dependent on the four members of the leukocyte integrin family of surface receptors. Organ transplantation triggers a range of immune responses aimed at rejecting the donor tissue. Engagement of cells of the immune system including T cells, B cells, and antigen presenting cells with each other or with the donor organ is an essential element of the rejection cascade, and this engagement is mediated by adhesions through the leukocyte integrins and their ligands. This review will first focus on the molecular mechanisms that regulate rapid activation of the leukocyte integrins by inside-out signaling that results in changes in receptor clustering on the leukocyte membrane and ligand affinity. Longer lasting changes in receptor expression through transcriptional mechanisms will also be discussed. The role of these receptors in organ transplant rejection, graft-versus-host disease, and ischemic reperfusion injury will also be reviewed. The potential of anti-adhesion therapy to prolong organ transplant survival will be discussed in both animal and patient studies.
Export Options
About this article
Cite this article as:
Noti D. John, Expression and Function of the Leukocyte Integrins in Organ Transplant Rejection, Current Medicinal Chemistry 2004; 11 (4) . https://dx.doi.org/10.2174/0929867043455945
DOI https://dx.doi.org/10.2174/0929867043455945 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Roles of TRAF6 in Central Nervous System
Current Neuropharmacology Cytokines in the Central Nervous System: Targets for Therapeutic Intervention
Current Drug Targets - CNS & Neurological Disorders Anti-inflammatory Action of Green Tea
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry Potential Approaches to Enhance the Effects of Estrogen on Senescent Blood Vessels and Postmenopausal Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Peptides Derived from Platelet Non-integrin Collagen-receptors or Types I and III Collagen Inhibit Collagen-Platelet Interaction
Cardiovascular & Hematological Disorders-Drug Targets Protease Inhibitors in the Clinic
Medicinal Chemistry Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
Current Medicinal Chemistry Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke
Current Neurovascular Research Antioxidative Properties of Flavonoids
Current Organic Chemistry Ventilation During Pediatric CPR
Current Pediatric Reviews Antiplatelet and Antileukocyte Effects of Cardiovascular,Immunomodulatory and Chemotherapeutic Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Application of Hematopoietic Cells to Therapeutic Angiogenesis
Current Pharmaceutical Design Microvascular Diseases: Is A New Era Coming?
Cardiovascular & Hematological Agents in Medicinal Chemistry Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine Upregulated Long Non-coding RNA ALMS1-IT1 Promotes Neuroinflammation by Activating NF-κB Signaling in Ischemic Cerebral Injury
Current Pharmaceutical Design Inhibition of Autophagy Potentiated Hippocampal Cell Death Induced by Endoplasmic Reticulum Stress and its Activation by Trehalose Failed to be Neuroprotective
Current Neurovascular Research Tetrahydrobiopterin: A Vascular Redox Target to Improve Endothelial Function
Current Vascular Pharmacology Immunophilins: Structures, Mechanisms and Ligands
Current Molecular Pharmacology